Concepts (70)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Ovarian Neoplasms | 4 | 2022 | 455 | 0.460 |
Why?
|
| Vulvar Neoplasms | 2 | 2022 | 20 | 0.350 |
Why?
|
| Adenocarcinoma, Sebaceous | 1 | 2022 | 8 | 0.190 |
Why?
|
| Sebaceous Gland Neoplasms | 1 | 2022 | 13 | 0.190 |
Why?
|
| Carcinoma in Situ | 1 | 2022 | 70 | 0.180 |
Why?
|
| Sertoli-Leydig Cell Tumor | 1 | 2022 | 17 | 0.180 |
Why?
|
| Sex Cord-Gonadal Stromal Tumors | 1 | 2021 | 11 | 0.180 |
Why?
|
| Ribonuclease III | 1 | 2022 | 100 | 0.170 |
Why?
|
| DEAD-box RNA Helicases | 1 | 2022 | 159 | 0.160 |
Why?
|
| Parovarian Cyst | 1 | 2020 | 10 | 0.160 |
Why?
|
| Myxoma | 1 | 2020 | 28 | 0.160 |
Why?
|
| Observer Variation | 1 | 2021 | 311 | 0.160 |
Why?
|
| Lymphatic Metastasis | 1 | 2021 | 424 | 0.160 |
Why?
|
| Lymph Nodes | 1 | 2021 | 360 | 0.150 |
Why?
|
| Carcinoma, Small Cell | 1 | 2018 | 38 | 0.140 |
Why?
|
| Fellowships and Scholarships | 1 | 2022 | 323 | 0.140 |
Why?
|
| Rare Diseases | 1 | 2020 | 208 | 0.140 |
Why?
|
| Papillomavirus Infections | 1 | 2022 | 384 | 0.140 |
Why?
|
| Endometriosis | 1 | 2021 | 169 | 0.140 |
Why?
|
| Laparoscopy | 2 | 2021 | 542 | 0.140 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2021 | 262 | 0.130 |
Why?
|
| Fertility Preservation | 1 | 2017 | 60 | 0.120 |
Why?
|
| Robotic Surgical Procedures | 1 | 2021 | 222 | 0.120 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2021 | 754 | 0.110 |
Why?
|
| Adenocarcinoma | 1 | 2021 | 987 | 0.100 |
Why?
|
| Internship and Residency | 1 | 2022 | 1211 | 0.090 |
Why?
|
| Female | 9 | 2022 | 70343 | 0.060 |
Why?
|
| Perilipin-2 | 1 | 2022 | 11 | 0.050 |
Why?
|
| Mutation | 3 | 2022 | 6129 | 0.050 |
Why?
|
| Biomarkers, Tumor | 2 | 2022 | 1608 | 0.050 |
Why?
|
| Humans | 10 | 2022 | 130403 | 0.050 |
Why?
|
| Accreditation | 1 | 2022 | 87 | 0.040 |
Why?
|
| Peutz-Jeghers Syndrome | 1 | 2021 | 28 | 0.040 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2018 | 1275 | 0.040 |
Why?
|
| Texas | 2 | 2020 | 3614 | 0.040 |
Why?
|
| Polycystic Ovary Syndrome | 1 | 2020 | 63 | 0.040 |
Why?
|
| Cohort Studies | 2 | 2020 | 5084 | 0.040 |
Why?
|
| Neoplasm Invasiveness | 1 | 2021 | 629 | 0.040 |
Why?
|
| Hysterectomy | 1 | 2021 | 200 | 0.040 |
Why?
|
| Hypercalcemia | 1 | 2018 | 41 | 0.040 |
Why?
|
| Child | 4 | 2020 | 26159 | 0.040 |
Why?
|
| Granulosa Cell Tumor | 1 | 2018 | 38 | 0.040 |
Why?
|
| Loss of Heterozygosity | 1 | 2018 | 124 | 0.030 |
Why?
|
| Codon, Nonsense | 1 | 2018 | 140 | 0.030 |
Why?
|
| Retrospective Studies | 3 | 2021 | 17633 | 0.030 |
Why?
|
| DNA Helicases | 1 | 2018 | 233 | 0.030 |
Why?
|
| Adolescent | 3 | 2021 | 20731 | 0.030 |
Why?
|
| Education, Medical, Graduate | 1 | 2022 | 552 | 0.030 |
Why?
|
| Biopsy | 1 | 2020 | 1239 | 0.030 |
Why?
|
| Laparotomy | 1 | 2017 | 138 | 0.030 |
Why?
|
| Recurrence | 1 | 2020 | 1475 | 0.030 |
Why?
|
| Heterozygote | 1 | 2018 | 721 | 0.030 |
Why?
|
| Ovary | 1 | 2018 | 353 | 0.030 |
Why?
|
| Hospitals, Pediatric | 1 | 2020 | 800 | 0.030 |
Why?
|
| Clinical Competence | 1 | 2022 | 1045 | 0.030 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2018 | 727 | 0.030 |
Why?
|
| Combined Modality Therapy | 1 | 2017 | 1233 | 0.030 |
Why?
|
| Neoplasm Staging | 1 | 2017 | 1300 | 0.030 |
Why?
|
| Aged | 2 | 2021 | 20899 | 0.020 |
Why?
|
| Incidence | 1 | 2020 | 3346 | 0.020 |
Why?
|
| Nuclear Proteins | 1 | 2018 | 1215 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2021 | 5204 | 0.020 |
Why?
|
| Prognosis | 1 | 2021 | 4901 | 0.020 |
Why?
|
| Middle Aged | 2 | 2021 | 28395 | 0.020 |
Why?
|
| Adult | 2 | 2021 | 31125 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2021 | 6773 | 0.020 |
Why?
|
| Transcription Factors | 1 | 2018 | 2437 | 0.020 |
Why?
|
| Young Adult | 1 | 2021 | 9974 | 0.020 |
Why?
|
| United States | 1 | 2022 | 11826 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2021 | 12852 | 0.010 |
Why?
|